Pharmacosmos has acquired 2 companies, including 2 in the last 5 years.
Pharmacosmos’ largest acquisition to date was in 2024, when it acquired G1 Therapeutics for $405M. Pharmacosmos has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
||
|---|---|---|---|---|---|---|---|---|
| 2024-08-07 |
G1 Therapeutics · Life Science
Research Triangle Park, North Carolina · www.g1therapeutics.com G1 Therapeutics is a commercial-stage oncology biopharmaceutical company developing and delivering next-generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA (trilaciclib). G1 Therapeutics is based in Research Triangle Park, North Carolina.
|
405
4.9x REVENUE |
Add-on Acquisition |
Pharmacosmos
|
- |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
